FDA Inspection 1008506 — Eurofins Biopharma Product Testing Australia Pty. Ltd.
The FDA completed an inspection of Eurofins Biopharma Product Testing Australia Pty. Ltd. on Mar 24, 2017 in Girraween. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Veterinary.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Mar 24, 2017
- Fiscal Year
- 2017
- Product Type
- Veterinary
- Project Area
- Monitoring of Marketed Animal Drugs, Feed, and Devices
- Location
- Girraween (Australia)